Geode Capital Management, LLC Stoke Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 870,831 shares of STOK stock, worth $9.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

870,831

Previous 794,170 9.65%

Holding current value

$9.6 Million

Previous $10.7 Million 0.25%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$12.24 - $15.92 $938,330 - $1.22 Million	76,661 Added 9.65%	870,831 $10.7 Million
Q2 2024 Aug 09, 2024	BUY	$11.03 - $17.52 $1.7 Million - $2.7 Million	154,363 Added 24.13%	794,170 $10.7 Million
Q1 2024 May 13, 2024	BUY	$4.12 - $14.17 $99,221 - $341,256	24,083 Added 3.91%	639,807 $8.64 Million
Q4 2023 Feb 13, 2024	BUY	$3.37 - $5.4 $82,925 - $132,877	24,607 Added 4.16%	615,724 $3.24 Million
Q3 2023 Nov 13, 2023	SELL	$3.78 - $11.99 $32,746 - $103,869	-8,663 Reduced 1.44%	591,117 $2.33 Million
Q2 2023 Aug 11, 2023	BUY	$7.93 - $13.82 $896,883 - $1.56 Million	113,100 Added 23.24%	599,780 $6.38 Million
Q1 2023 May 15, 2023	BUY	$7.65 - $10.38 $95,288 - $129,293	12,456 Added 2.63%	486,680 $4.05 Million
Q4 2022 Feb 13, 2023	BUY	$7.07 - $15.69 $98,760 - $219,173	13,969 Added 3.04%	474,224 $4.38 Million
Q3 2022 Nov 14, 2022	BUY	$12.56 - $22.53 $206,561 - $370,528	16,446 Added 3.71%	460,255 $5.91 Million
Q2 2022 Aug 12, 2022	BUY	$10.36 - $23.93 $83,273 - $192,349	8,038 Added 1.84%	443,809 $5.86 Million
Q1 2022 May 13, 2022	BUY	$17.19 - $26.1 $1.02 Million - $1.56 Million	59,617 Added 15.85%	435,771 $9.17 Million
Q4 2021 Feb 11, 2022	BUY	$18.11 - $30.72 $232,152 - $393,799	12,819 Added 3.53%	376,154 $9.02 Million
Q3 2021 Nov 12, 2021	BUY	$23.65 - $34.44 $167,654 - $244,145	7,089 Added 1.99%	363,335 $9.24 Million
Q2 2021 Aug 13, 2021	BUY	$30.53 - $41.09 $1.93 Million - $2.6 Million	63,210 Added 21.57%	356,246 $12 Million
Q1 2021 May 12, 2021	BUY	$36.08 - $69.81 $789,105 - $1.53 Million	21,871 Added 8.07%	293,036 $11.4 Million
Q4 2020 Feb 12, 2021	BUY	$33.62 - $61.93 $2.32 Million - $4.27 Million	68,976 Added 34.11%	271,165 $16.8 Million
Q3 2020 Nov 13, 2020	BUY	$22.23 - $37.48 $939,106 - $1.58 Million	42,245 Added 26.41%	202,189 $6.77 Million
Q2 2020 Aug 13, 2020	SELL	$20.26 - $29.73 $524,977 - $770,363	-25,912 Reduced 13.94%	159,944 $3.81 Million
Q1 2020 May 14, 2020	BUY	$16.8 - $34.15 $1.11 Million - $2.26 Million	66,139 Added 55.25%	185,856 $4.26 Million
Q4 2019 Feb 13, 2020	BUY	$20.01 - $30.79 $139,369 - $214,452	6,965 Added 6.18%	119,717 $3.39 Million
Q3 2019 Nov 12, 2019	BUY	$20.53 - $37.72 $2.31 Million - $4.25 Million	112,752 New	112,752 $2.42 Million

Others Institutions Holding STOK

# of Institutions

125

Shares Held

57.6M

Call Options Held

9.3K

Put Options Held

35.2K

View Full List

About Stoke Therapeutics, Inc.

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $434M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

More about STOK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Stoke Therapeutics, Inc. Transaction History